Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | April 2005 |
| End Date: | April 2013 |
The purpose of this study is to determine whether a brief course of SSKI (saturated solution
of potassium iodide) administered preoperatively provides any benefit in the surgical
management of patients undergoing thyroidectomy as definitive management of their Graves
Disease.
of potassium iodide) administered preoperatively provides any benefit in the surgical
management of patients undergoing thyroidectomy as definitive management of their Graves
Disease.
Historically Potassium Iodide was given to patients for 1 week prior to thyroidectomy. This
common practice was used to decrease thyroid function and prevent thyroid storm during the
thyroidectomy. However, in modern practice, nearly all patients presenting for surgical
management have been made euthyroid through the use of medications such as propylthiouracil.
Despite this potassium iodine continues to be administered with the presumption that it
decreases the friability of the gland making surgery easier, with less blood loss.
The outcomes to be measured in this surgery are operative time, operative complications and
blood loss.
common practice was used to decrease thyroid function and prevent thyroid storm during the
thyroidectomy. However, in modern practice, nearly all patients presenting for surgical
management have been made euthyroid through the use of medications such as propylthiouracil.
Despite this potassium iodine continues to be administered with the presumption that it
decreases the friability of the gland making surgery easier, with less blood loss.
The outcomes to be measured in this surgery are operative time, operative complications and
blood loss.
Inclusion Criteria:
- Adult patients with a clinical diagnosis of Graves Disease
- Patients who have selected surgical resection as treatment of their Graves Disease
- Prior use of anti thyroid medication so that patient is clinically and biochemically
euthyroid
Exclusion Criteria:
- Patients deemed unfit for surgery by operating surgeon or anesthesist
- Patients who are clinically hyperthyroid or have T3 or T4 levels 2X the upper limit
of normal
We found this trial at
1
site
Click here to add this to my saved trials
